Skip to content

13F-HR filed by Iron Triangle Partners LP

Iron Triangle Partners LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 24 holding rows worth $397,078,000.

Accession
0001172661-20-001738
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 24 entries on the cover page, a total value of $397,078,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $397,078,000 with VALUE read as thousands by filing date, 13F file number 028-20024. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ENCOMPASS HEALTH CORP COM29261A100Stock550,000$34,062,000thousands by filing date
HOLOGIC INC436440101COM500,000$28,500,000thousands by filing date
BAXTER INTL INC071813109COM330,000$28,413,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS436,127$24,240,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM130,000$22,666,000thousands by filing date
Boston Scientific Corporation101137107COM600,000$21,066,000thousands by filing date
CATALENT INC USD 0.01148806102COM280,000$20,524,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock137,577$19,519,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM420,510$19,049,000thousands by filing date
NEVRO CORP64157F103COM150,485$17,978,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM100,000$17,798,000thousands by filing date
Bristol-Myers Squibb Company110122108COM287,710$16,917,000thousands by filing date
INOVALON HLDGS INC45781D101COM CL A733,053$14,119,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock165,500$13,427,000thousands by filing date
MCKESSON CORP COM58155Q103Stock85,000$13,041,000thousands by filing date
CHANGE HEALTHCARE INC15912K100COM1,147,800$12,855,000thousands by filing date
AXONICS INC05465P101COM347,591$12,204,000thousands by filing date
Bristol-Myers Squibb Company110122108COM200,000$11,760,000thousands by filing datecall
ENVISTA HOLDINGS CORPORATION29415F104COM500,000$10,545,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock116,054$10,099,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock70,000$8,355,000thousands by filing date
SURGERY PARTNERS INC86881A100COM676,652$7,829,000thousands by filing date
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock150,000$7,257,000thousands by filing date
ROYALTY PHARMA PLCG7709Q104SHS CLASS A100,000$4,855,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-20-001738this filing2020-08-14acceptance time not in the bulk data set